Electronic Symptom Monitoring of Patient-Reported Outcomes Among Patients With Hepatocellular Carcinoma During Immunotherapy (PRIME-HCC): Protocol for a Randomised Controlled Trial
Clinical trial NCT06938945 · RECRUITING
Trial details
- NCT number
- NCT06938945
- Sponsor
- Wei Xiaoping
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-24
- Primary completion
- 2026-08-31
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.